Publications by authors named "Marta Cobham"

Claim this Profile
T
Tetrathiomolybdate (TM)-associated copper depletion influences collagen remodeling and immune response in the pre-metastatic niche of breast cancer.
Ying L Liu, Cecilie Liv Bager, Nicholas Willumsen, Divya Ramchandani, Naomi Kornhauser, Marta Cobham

NPJ Breast Cancer· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Influencing the Tumor Microenvironment: A Phase II Study of Copper Depletion Using Tetrathiomolybdate in Patients with Breast Cancer at High Risk for Recurrence and in Preclinical Models of Lung Metastases.
Nancy Chan, Amy Willis, Naomi Kornhauser, Maureen M Ward, Sharrell B Lee, Marta Vallee Cobham

Clin Cancer Res· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pro1170 Ala polymorphism in HER2-neu is associated with risk of trastuzumab cardiotoxicity.
Sasha E Stanton, Maureen M Ward, Paul Christos, Rachel Sanford, Christina Lam, Marta V Cobham

BMC Cancer· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ixabepilone-induced mitochondria and sensory axon loss in breast cancer patients.
Gigi J Ebenezer, Karen Carlson, Diana Donovan, Marta Cobham, Ellen Chuang

Ann Clin Transl Neurol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incremental increase in VEGFR1⁺ hematopoietic progenitor cells and VEGFR2⁺ endothelial progenitor cells predicts relapse and lack of tumor response in breast cancer patients.
Sarika Jain, Maureen M Ward, Jennifer O'Loughlin, Marissa Boeck, Naomi Wiener, Marta V Cobham

Breast Cancer Res Treat· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ixabepilone: a new treatment option for the management of taxane-resistant metastatic breast cancer.
Marta Vallee Cobham, Diana Donovan

Cancer Manag Res· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1/2 clinical trial of interferon alpha2b and weekly liposome-encapsulated all-trans retinoic acid in patients with advanced renal cell carcinoma.
Stephen A Boorjian, Matthew I Milowsky, Jodi Kaplan, Martin Albert, Marta Vallee Cobham

J Immunother· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis